Full Text
HTA7 Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans

Abstract

Authors

Daniel Enright James Chambers

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×